期刊文献+

2型糖尿病患者血糖控制与良性前列腺增生的相关性研究 被引量:10

Correlation of Diabetes Control with Benign Prostatic Hyperplasia in T2DM Patients
暂未订购
导出
摘要 目的探讨2型糖尿病(T2DM)患者血糖控制与良性前列腺增生(BPH)的相关性。方法选择2010年10月—2012年8月我院老年科住院男性患者154例,分为对照组67例、血糖控制达标组46例和血糖控制不达标组41例。测量各组血压、身高、体质量,计算体质指数(BMI);检测各组空腹血糖(FPG)、总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、糖化血红蛋白(HbA1c)、前列腺特异性抗原(PSA)等。超声测量前列腺纵径、横径及前后径,计算前列腺体积(PV)及PV年增长率。结果血糖控制不达标组PV明显高于对照组和血糖控制达标组(q值分别为-3.02和-2.00,P<0.05);血糖控制不达标组PV年增长率明显高于对照组和血糖控制达标组(q值分别为-3.19和-2.48,P<0.05);Pearson相关分析结果显示,HbA1c、FPG、PSA与PV呈正相关(r值分别为0.260、0.195、0.363,P<0.05),HDL-C与PV呈负相关(r=-0.192,P<0.05);HbA1c、FPG、LDL-C、PSA与PV年增长率呈正相关(r值分别为0.272、0.219、0.164、0.348,P<0.05),HDL-C与PV年增长率呈负相关(r=-0.216,P<0.05)。结论良好的血糖控制可有效减慢前列腺体积的增长速度,延缓BPH病情进展。 Objective To evaluate the relationship between diabetes control and benign prostatic hyperplasia (BPH) in type 2 diabetes mellitus (T2DM). Methods Totally 154 male T2DM patients were divided into groups A (control group, n = 67), B ( blood glucose controlled to standard, n = 46), C (blood glucose controlled not to standard, n = 41 ). Blood pres- sure, body weight, body height were measured, body mass index (BMI) calculated, levels of serum fast glucose (FPG), to- tal cholesterol (TC), triglycerides (TG), low -density lipoprotein cholesterol (LDL- C), high -density lipoprotein choles- terol (HDL - C), glycosylated hemoglobin ( HbA1c ) and prostate - specific antigen (PSA) detected. Total prostate volume (PV) were measured by ultrasound. Results PV increased significantly in group C as compared with groups A and B (q = -3.02, -2. 00, P 〈 0.05 ) ; Annual PV growth rate was significantly higher in group C than in groups A, B (q = -3. 19, -2.48, P〈0.05); By Pearson correlation analysis, PV was positively correlated with HbA1c, FPG, PSA (r = 0.260, 0. 195, 0. 363, P 〈0. 05 ), negatively with HDL- C (r = -0. 192, P 〈 0.05 ) ; Annual PV growth rate was positively corre- lated with HbA1c, FPG, LDL - C and PSA ( r = 0. 272, 0. 219, 0. 164, 0. 348, P 〈 0. 05), negatively with HDL - C (r = - 0. 216, P 〈 0. 05). Conclusion Well controlling blood glucose can slow down effectively the growth rate of PV and delay BPH progression.
出处 《中国全科医学》 CAS CSCD 北大核心 2013年第23期2671-2673,共3页 Chinese General Practice
关键词 前列腺增生 糖尿病 2型 血糖 Prostatic hyperplasia Diabetes mellitus, type 2 Blood glucose
  • 相关文献

参考文献19

  • 1中国2型糖尿病防治指南(2010年版)[J].中国实用乡村医生杂志,2012,19(4):1-15. 被引量:336
  • 2Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia [ J]. J Clin Endocrinol Metab, 2006, 91 (7) : 2562 -2568.
  • 3Hammarsten J, Damber JE, Karlsson M, et al. Insulin and free oes- tradiol are independent risk factors for benign prostatic hyperplasia [ J ]. Prostate Cancer and Prostatic Diseases, 2009, 12 (2) : 160 - 165.
  • 4Meigs JB, Mohr B, Barry MJ, et al. Risk factors for clinical benign prostatic hyperplasia in a community - based population of healthy aging men [J]. J Clin Epidemiol, 2001, 54 (9): 935-944.
  • 5Joseph MA, Harlow SD, Wei JT, et al. Risk factors for lower urinary tract symptoms in a population - based sample of African - American men [J]. Am J Epidemiol, 2003, 157 (10) : 906-914.
  • 6Sandfeldt L, Hahn RG. Cardiovascular risk factors correlate with pros- tate size in men with bladder outlet obstruction [ J ]. BJU Int, 2003,92 (1): 64-68.
  • 7Kupelian V, McVary KT, Kaplan SA, et al. Association of lower uri- nary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey [J]. J Urol, 2009, 182 (2) : 616 - 625.
  • 8帕力达.阿不力孜,玛依拉.阿不都克力木,周晓辉,王宁.糖尿病与良性前列腺增生的相关性研究[J].心血管康复医学杂志,2011,20(4):303-307. 被引量:9
  • 9崔师玉,李茵茵,陈海燕,车筱琪,王哲,周洁.2型糖尿病与良性前列腺增生症的相关性研究[J].中国老年学杂志,2010,30(1):26-27. 被引量:9
  • 10Kim WT, Yun SJ, Choi YD, et al. Prostate size correlates with fast- ing blood glucose in non - diabetic benign prostatic hyperplasia patients with normal testosterone levels [ J]. J Korean Med Sci, 2011, 26 (9): 1214 -1218.

二级参考文献24

  • 1朱伯兰.良性前列腺增生与高血压、冠心病、糖尿病的关系探讨[J].世界今日医学杂志,2000,1(2):115-117. 被引量:10
  • 2马萍,刘晓方,徐清斌.2型糖尿病与冠心病危险性相关机制的研究进展[J].心血管康复医学杂志,2004,13(5):511-512. 被引量:14
  • 3李培军,张祥华,郭利君,那彦群.高血压对良性前列腺增生细胞增殖与凋亡的影响[J].中华男科学杂志,2005,11(2):94-97. 被引量:31
  • 4洪鸣鸣.良性前列腺增生症和内科疾病的关系[J].中华老年医学杂志,2006,25(11):807-808. 被引量:10
  • 5Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia [ J ], J Clin Endocrinol Metab, 2006 ;91 ( 7 ) : 2562-8.
  • 6Dahle SE, Chokkalingam AP, Gao YT, et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia [ J]. J Urol,2002 ; 168 (2) :599-604.
  • 7Hamrnarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia[ J]. Eur Urol,2001 ;39(2) :151-8.
  • 8Ozden C, Ozdal OL, Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia[ J]. Eur Urol,2007 ;51 ( 1 ) : 199-203.
  • 9Chan JM, Stampfer M J, Giovannucci E, et al. Plasma insulin-like growth factor-1 and prostate cancer risk: aprospective [ J]. Science, 1998;279 (5350) :563-6.
  • 10Stattin P, Kaaks R, Riboli E, et al. Circulating insulin-like growth factor-1 and benign prostatic hyperplasia-prospective study [ J ]. Scand J Urol Nephrol, 2001 ; 35 ( 2 ) : 122 -6.

共引文献357

同被引文献63

  • 1逄瑷博,吕俊刚,黄薇,凌存保,林凡丹,张春燕,田亚平.中年良性前列腺增生患者性激素水平与胰岛素抵抗的相关性分析[J].武警医学,2023,34(12):1050-1054. 被引量:3
  • 2任瑞民,马丁,付永强,尚吉文.代谢综合征后前列腺增生风险预测列线图模型的建立[J].微创泌尿外科杂志,2022,11(1):43-46. 被引量:4
  • 3郭利君,张祥华,李培军,那彦群.高血压对良性前列腺增生组织中血管新生影响的研究[J].中华医学杂志,2005,85(9):606-609. 被引量:30
  • 4CHEN Li-ying,ZHU Wen-hua,CHEN Zhou-wen,DAI Hong-lei,REN Jing-jing,CHEN Jian-hua,CHEN Lei-qian,FANG Li-zheng.Relationship between hyperuricemia and metabolic syndrome[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2007,8(8):593-598. 被引量:54
  • 5那彦群, 叶章群, 孙颖浩, 等. 2014版中国泌尿外科疾病诊断治疗指南[M]. 北京: 人民卫生出版, 2014: 277-278.
  • 6Qu x, Huang Z, Meng X, et al. Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients [ J]. Int Urol Nephrol,2014,46(3 ) :499-504.
  • 7Joseph MA, Harlow SD, Wei JT, et al. Risk factors for lower uri- nary tract symptoms in a population-based sample of African-Amer- ican men [ J ]. Am J Epidemio1.2003.157 ( 10 ) : 906 -914.
  • 8中华医学会糖尿病学分会.2013年版中国糖尿病防治指南[M].北京:北京大学医学出版社,2014:8-9.
  • 9Parsons JK, Carter HB, Partin AW, et al. Metabolic factors asso- ciated with benign prostatic hyperplasia [ J ]. J Clin Endocrinol Metab, 2006,91 ( 7 ) : 2562 -2568.
  • 10Hammarsten J, Damber JE, Karlsson M, et al. Insulin and free oestradiol are independent risk factors for benign prostatic hyper- plasia [ J ]. Prostate Cancer Prostatic Dis, 2009,12 ( 2 ) : 160 - 165.

引证文献10

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部